Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma.

Literature DB >> 25869115

Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma.

Mirko Manetti¹.

Abstract

Entities: Disease

Keywords: M2 macrophages; alternative macrophage activation; dermal fibrosis; localized scleroderma; systemic sclerosis

Mesh：

Substances：

Year: 2015 PMID： 25869115 DOI： 10.1111/exd.12727

Source DB: PubMed Journal: Exp Dermatol ISSN： 0906-6705 Impact factor: 3.960

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

Review 1. Update on macrophages and innate immunity in scleroderma.

Authors: Jennifer J Chia; Theresa T Lu
Journal: Curr Opin Rheumatol Date: 2015-11 Impact factor: 5.006

Review 2. Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

Authors: Gabriela Kania; Michal Rudnik; Oliver Distler
Journal: Nat Rev Rheumatol Date: 2019-05 Impact factor: 20.543

3. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.

Authors: Stefano Soldano; Carmen Pizzorni; Sabrina Paolino; Amelia Chiara Trombetta; Paola Montagna; Renata Brizzolara; Barbara Ruaro; Alberto Sulli; Maurizio Cutolo
Journal: PLoS One Date: 2016-11-15 Impact factor: 3.240

Review 4. Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis.

Authors: Theodoros-Ioannis Papadimitriou; Arjan van Caam; Peter M van der Kraan; Rogier M Thurlings
Journal: Biomedicines Date: 2022-01-29

5. Scleroderma-like Impairment in the Network of Telocytes/CD34⁺ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis.

Authors: Irene Rosa; Eloisa Romano; Bianca Saveria Fioretto; Daniele Guasti; Lidia Ibba-Manneschi; Marco Matucci-Cerinic; Mirko Manetti
Journal: Int J Mol Sci Date: 2021-11-17 Impact factor: 5.923

6. Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors: Qiuhong Wu; Yang Liu; Yan Xie; Shixiong Wei; Yi Liu
Journal: Front Cell Dev Biol Date: 2021-06-17

Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma.

Review 1. Update on macrophages and innate immunity in scleroderma.

Review 2. Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

3. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.

Review 4. Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis.

5. Scleroderma-like Impairment in the Network of Telocytes/CD34⁺ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis.

6. Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.

Review 7. Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease.

Review 8. Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

9. Black, White, and Gray: Macrophages in Skin Repair and Disease.

10. Transcriptome analysis reveals key genes modulated by ALK5 inhibition in a bleomycin model of systemic sclerosis.

Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma.

Review 1. Update on macrophages and innate immunity in scleroderma.

Review 2. Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

3. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.

Review 4. Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis.

5. Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis.

6. Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.

Review 7. Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease.

Review 8. Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

9. Black, White, and Gray: Macrophages in Skin Repair and Disease.

10. Transcriptome analysis reveals key genes modulated by ALK5 inhibition in a bleomycin model of systemic sclerosis.

5. Scleroderma-like Impairment in the Network of Telocytes/CD34⁺ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis.